The company had earlier said that USFDA issued seven observations
after conducting a routine 'CGMP inspection' at Cipla's API
manufacturing facility in Virgonangar, Bengaluru.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-announces-closure-of-usfda-inspection-at-bengaluru-facility/articleshow/71244938.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment